001     274030
005     20250119000233.0
024 7 _ |a 10.1017/S1041610223004489
|2 doi
024 7 _ |a pmid:38186227
|2 pmid
024 7 _ |a 1041-6102
|2 ISSN
024 7 _ |a 1741-203X
|2 ISSN
024 7 _ |a altmetric:169811399
|2 altmetric
037 _ _ |a DZNE-2025-00011
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Dichter, Martin
|0 P:(DE-2719)2451281
|b 0
|u dzne
245 _ _ |a Intervention for sleep problems in nursing home residents with dementia: a cluster-randomized study.
260 _ _ |a Cambridge
|c 2024
|b Cambridge Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1736763333_1045
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a To reduce sleep problems in people living with dementia using a multi-component intervention.Cluster-randomized controlled study with two parallel groups and a follow-up of 16 weeks.Using external concealed randomization, 24 nursing homes (NH) were allocated either to the intervention group (IG, 12 clusters, 126 participants) or the control group (12 clusters, 116 participants).Participants were eligible if they had dementia or severe cognitive impairment, at least two sleep problems, and residence of at least two weeks in a NH.The 16-week intervention consists of six components: (1) assessment of sleep-promoting activities and environmental factors in NHs, (2) implementation of two 'sleep nurses,' (3) basic education, (4) advanced education for staff, (5) workshops to develop sleep-promoting concepts, and (6) written information and education materials. The control group (CG) received standard care.Primary outcome was ≥ two sleep problems after 16 weeks assessed with the Sleep Disorders Inventory (SDI).Twenty-two clusters (IG = 10, CG = 12) with 191 participants completed the study. At baseline, 90% of people living with dementia in the IG and 93% in the CG had at least two sleep problems. After 16 weeks, rates were 59.3% (IG) vs 83.8% (CG), respectively, a difference of -24.5% (95% CI, -46.3% - -2.7%; cluster-adjusted odds ratio 0.281; 95% CI 0.087-0.909). Secondary outcomes showed a significant difference only for SDI scores after eight and 16 weeks.The MoNoPol-Sleep intervention reduced sleep problems of people living with dementia in NH compared to standard care.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a complex interventions
|2 Other
650 _ 7 |a dementia
|2 Other
650 _ 7 |a dyssomnias
|2 Other
650 _ 7 |a nursing homes
|2 Other
650 _ 7 |a person-centered care
|2 Other
650 _ 7 |a sleep
|2 Other
650 _ 7 |a sleep problems
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Nursing Homes
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Dementia: complications
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Sleep Wake Disorders: therapy
|2 MeSH
650 _ 2 |a Aged, 80 and over
|2 MeSH
650 _ 2 |a Homes for the Aged
|2 MeSH
650 _ 2 |a Cluster Analysis
|2 MeSH
700 1 _ |a Dörner, Jonas
|0 P:(DE-2719)9002752
|b 1
|u dzne
700 1 _ |a Wilfling, Denise
|b 2
700 1 _ |a Berg, Almuth
|b 3
700 1 _ |a Klatt, Thomas
|b 4
700 1 _ |a Möhler, Ralph
|b 5
700 1 _ |a Haastert, Burkhard
|b 6
700 1 _ |a Meyer, Gabriele
|b 7
700 1 _ |a Halek, Margareta
|0 P:(DE-2719)2191593
|b 8
|u dzne
700 1 _ |a Köpke, Sascha
|b 9
773 _ _ |a 10.1017/S1041610223004489
|g Vol. 36, no. 10, p. 965 - 978
|0 PERI:(DE-600)2147136-8
|n 10
|p 965 - 978
|t International psychogeriatrics
|v 36
|y 2024
|x 1041-6102
856 4 _ |u https://pub.dzne.de/record/274030/files/DZNE-2025-00011_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/274030/files/DZNE-2025-00011_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |o oai:pub.dzne.de:274030
|p VDB
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 0
|6 P:(DE-2719)2451281
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)9002752
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 8
|6 P:(DE-2719)2191593
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-08-19
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-19
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1180
|2 StatID
|b Current Contents - Social and Behavioral Sciences
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0130
|2 StatID
|b Social Sciences Citation Index
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-08-19
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT PSYCHOGERIATR : 2022
|d 2023-08-19
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INT PSYCHOGERIATR : 2022
|d 2023-08-19
920 1 _ |0 I:(DE-2719)1610002
|k AG Holle
|l Care Structures
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1610002
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21